87 related articles for article (PubMed ID: 17630958)
1. NALP1 and the inflammasomes: challenging our perception of vitiligo and vitiligo-related autoimmune disorders.
Taïeb A
Pigment Cell Res; 2007 Aug; 20(4):260-2. PubMed ID: 17630958
[No Abstract] [Full Text] [Related]
2. NALP1 in vitiligo-associated multiple autoimmune disease.
Jin Y; Mailloux CM; Gowan K; Riccardi SL; LaBerge G; Bennett DC; Fain PR; Spritz RA
N Engl J Med; 2007 Mar; 356(12):1216-25. PubMed ID: 17377159
[TBL] [Abstract][Full Text] [Related]
3. Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs.
Alkhateeb A; Qarqaz F
Arch Dermatol Res; 2010 Oct; 302(8):631-4. PubMed ID: 20574744
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms and functions of inflammasomes.
Lamkanfi M; Dixit VM
Cell; 2014 May; 157(5):1013-22. PubMed ID: 24855941
[TBL] [Abstract][Full Text] [Related]
5. Inflammasome activation and vitiligo/nonsegmental vitiligo progression.
Marie J; Kovacs D; Pain C; Jouary T; Cota C; Vergier B; Picardo M; Taieb A; Ezzedine K; Cario-André M
Br J Dermatol; 2014 Apr; 170(4):816-23. PubMed ID: 24734946
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population.
Jin Y; Birlea SA; Fain PR; Spritz RA
J Invest Dermatol; 2007 Nov; 127(11):2558-62. PubMed ID: 17637824
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune blistering disease in a patient with Graves disease and vitiligo.
Soultati AS; Dourakis SP; Asvesti K; Nezi V; Alexopoulou A; Archimandritis AJ
Am J Med Sci; 2007 May; 333(5):309-12. PubMed ID: 17505176
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.
Kotobuki Y; Tanemura A; Yang L; Itoi S; Wataya-Kaneda M; Murota H; Fujimoto M; Serada S; Naka T; Katayama I
Pigment Cell Melanoma Res; 2012 Mar; 25(2):219-30. PubMed ID: 22136309
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of experimental autoimmune vitiligo by oral administration of mushroom tyrosinase.
Zehtab T; Yazdanparast R; Rafieii S
Cytobios; 2001; 105(408):27-34. PubMed ID: 11368265
[TBL] [Abstract][Full Text] [Related]
10. Vitiligo in an Italian outpatient center: a clinical and serologic study of 204 patients in Tuscany.
Berti S; Bellandi S; Bertelli A; Colucci R; Lotti T; Moretti S
Am J Clin Dermatol; 2011 Feb; 12(1):43-9. PubMed ID: 21110525
[TBL] [Abstract][Full Text] [Related]
11. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation.
Faustin B; Lartigue L; Bruey JM; Luciano F; Sergienko E; Bailly-Maitre B; Volkmann N; Hanein D; Rouiller I; Reed JC
Mol Cell; 2007 Mar; 25(5):713-24. PubMed ID: 17349957
[TBL] [Abstract][Full Text] [Related]
12. Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease.
Plettenberg H; Assmann T; Ruzicka T
Arch Dermatol; 2003 May; 139(5):651-4. PubMed ID: 12756103
[No Abstract] [Full Text] [Related]
13. [Autoantibodies in vitiligo. Clinical significance].
Morgan M; Castells A; Ramírez A
Med Cutan Ibero Lat Am; 1986; 14(2):139-42. PubMed ID: 3528710
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 and Bcl-XL regulate proinflammatory caspase-1 activation by interaction with NALP1.
Bruey JM; Bruey-Sedano N; Luciano F; Zhai D; Balpai R; Xu C; Kress CL; Bailly-Maitre B; Li X; Osterman A; Matsuzawa S; Terskikh AV; Faustin B; Reed JC
Cell; 2007 Apr; 129(1):45-56. PubMed ID: 17418785
[TBL] [Abstract][Full Text] [Related]
15. Update on childhood vitiligo.
Silverberg NB
Curr Opin Pediatr; 2010 Aug; 22(4):445-52. PubMed ID: 20616733
[TBL] [Abstract][Full Text] [Related]
16. The genetics of generalized vitiligo.
Spritz RA
Curr Dir Autoimmun; 2008; 10():244-57. PubMed ID: 18460890
[TBL] [Abstract][Full Text] [Related]
17. [Term 5: Neutrophil extracellular traps and inflammasomes].
Ishibashi K
Med Mycol J; 2015; 56(1):J41. PubMed ID: 25855027
[No Abstract] [Full Text] [Related]
18. Inflammasomes and human autoimmunity: A comprehensive review.
Yang CA; Chiang BL
J Autoimmun; 2015 Jul; 61():1-8. PubMed ID: 26005048
[TBL] [Abstract][Full Text] [Related]
19. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes.
Magitta NF; Bøe Wolff AS; Johansson S; Skinningsrud B; Lie BA; Myhr KM; Undlien DE; Joner G; Njølstad PR; Kvien TK; Førre Ø; Knappskog PM; Husebye ES
Genes Immun; 2009 Mar; 10(2):120-4. PubMed ID: 18946481
[TBL] [Abstract][Full Text] [Related]
20. Modern genetics, ancient defenses, and potential therapies.
Gregersen PK
N Engl J Med; 2007 Mar; 356(12):1263-6. PubMed ID: 17377166
[No Abstract] [Full Text] [Related]
[Next] [New Search]
